文献速递脑血管病

卵圆孔未闭封堵术后心房颤动的系统评价与荟萃分析

Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials.
PubMed 文献 · Stroke · 2021-02-22

该系统评价与荟萃分析纳入6项随机对照试验(3737例)和26项观察性研究(9126例),评估经皮卵圆孔未闭(PFO)封堵术后心房颤动(AF)的发生频率及预测因素。封堵术后AF发生率为3.7例/100患者年(95%CI 2.6–4.9),风险集中于术后45天内(27.2例/100患者年,95%CI 20.1–34.81),45天后降至1.3例/100患者年(95%CI 0.3–2.7)。与药物治疗相比,PFO封堵与AF风险增加相关(OR 5.3,95%CI 2.5–11.41;P<0.001),且年龄较大的研究报道AF发生率更高(P=0.001)。

要点

  • PFO封堵术后AF发生率约3.7例/100患者年,风险集中于术后45天内。
  • 与药物治疗相比,PFO封堵与AF风险增加相关(OR 5.3,95%CI 2.5–11.41)。
  • 年龄较大的患者研究报道AF发生率更高(P=0.001)。

核心结论

  • PFO封堵患者AF发生率高于药物治疗患者,风险集中于术后45天内且与年龄较大相关。

研究设计与样本

  • 系统检索EMBASE和MEDLINE数据库(2019年7月11日),纳入6项随机对照试验(3737例)和26项观察性研究(9126例)。
  • 采用随机效应模型进行比例荟萃分析。

主要发现

  • PFO封堵术后AF发生率为3.7例/100患者年(95%CI 2.6–4.9)。
  • 术后45天内AF发生率为27.2例/100患者年(95%CI 20.1–34.81),45天后为1.3例/100患者年(95%CI 0.3–2.7)。
  • 药物治疗患者AF发生率为0.1例/100患者年(95%CI 0.0–0.4)。
  • PFO封堵与药物治疗相比AF风险增加(OR 5.3,95%CI 2.5–11.41;P<0.001)。
  • 年龄较大的研究报道AF发生率更高(P=0.001)。

关键数值与推荐

  • PFO封堵术后AF总体发生率3.7例/100患者年(95%CI 2.6–4.9)。
  • 术后45天内AF发生率27.2例/100患者年(95%CI 20.1–34.81),45天后1.3例/100患者年(95%CI 0.3–2.7)。
  • 药物治疗患者AF发生率0.1例/100患者年(95%CI 0.0–0.4)。
  • PFO封堵 vs 药物治疗AF风险OR 5.3(95%CI 2.5–11.41;P<0.001)。
  • 年龄与AF发生率相关的荟萃回归P=0.001。

临床怎么用

  • PFO封堵术后应重点关注术后45天内AF的发生,尤其对年龄较大的患者加强监测。
  • 对PFO封堵患者需权衡AF风险与缺血性卒中预防获益,并制定个体化抗栓策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Multiple studies evaluated whether patent foramen ovale (PFO) closure reduces the risk of ischemic stroke. One commonly reported complication of PFO closure is the development of atrial fibrillation (AF), which is itself a powerful stroke risk factor that requires specific management. This study aims to evaluate the frequency of AF in patients post-percutaneous closure of PFO and the clinical factors that predict AF detection. METHODS: Studies were identified by systematically searching EMBASE and MEDLINE databases on July 11, 2019. Meta-analysis of proportions was performed, assuming a random-effects model. RESULTS: A total of 6 randomized controlled trials and 26 observational studies were included, comprising 3737 and 9126 patients, respectively. After PFO closure, the rate of AF development was 3.7 patients per 100 patient-years of follow-up (95% CI, 2.6–4.9). The risk of AF development is concentrated in the first 45 days post-procedure (27.2 patients per 100 patient-years [95% CI, 20.1–34.81], compared with 1.3 patients per 100 patient-years [95% CI, 0.3–2.7]) after 45 days. Meta-regression by age suggested that studies with older patients reported higher rate of AF (P=0.001).In medically treated patients, the rate of AF development was 0.1 per 100 patient-years of follow-up (95% CI, 0.0–0.4). Closure of PFO is associated with increased risk of AF compared with medical management (odds ratio, 5.3 [95% CI, 2.5–11.41]; P<0.001). CONCLUSIONS: AF is more common in PFO patients who had percutaneous closure compared with those who were medically treated. The risk of AF was higher in the first 45 days post-closure and in studies that included patients with increased age.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chen JZ, Thijs VN. Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials. Stroke. 2021. PMID: 33611943. doi:10.1161/STROKEAHA.120.030293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。